|Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.
|The Journal of allergy and clinical immunology.
|Anti‐IL‐5 therapies for asthma.
|Cochrane Database of Systematic Reviews
|Comparative efficacy and safety of tezepelumab and other biologics in patients with inadequately controlled asthma according to thresholds of type 2 inflammatory biomarkers: a systematic review and network meta-analysis.
|Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis.
|Clinical and experimental allergy
|Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.
|The Journal of allergy and clinical immunology
|Comparative efficacy and safety of dupilumab and benralizumab in patients with inadequately controlled asthma: a systematic review.
|International Journal of Molecular Sciences
|Effect of monoclonal antibody drug therapy on mucosal biomarkers in airway disease: a systematic review.
|Clinical and Experimental Allergy
|Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma.
|Clinical review report: benralizumab (Fasenra).
|Adverse events of benralizumab in moderate to severe eosinophilic asthma: a meta-analysis.
|Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.
|BMC Respiratory Journal
|Australian public assessment report for benralizumab.
|Australian Government: Department of Health
|Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks.
|Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review.
|European Respiratory Journal